Monthly Investor Report - December 2025

Summary by AI BETAClose X

Ruffer Investment Company Limited reported a flat portfolio performance in December 2025, consolidating a year of double-digit returns net of fees, with gold equities being the largest contributor. The company continued its share buyback program, purchasing 6.8 million shares in the final quarter, bringing the annual total to 38 million shares or £105m, representing 11% of shares outstanding at the start of the year. Derivative protections detracted from performance due to low volatility and tightening credit spreads, while fixed income holdings were neutral, with portfolio duration reduced to below two years. The company is maintaining a disciplined stance for 2026, reinforcing exposure to growth opportunities while preserving its defensive spine.

Disclaimer*

Ruffer Investment Company Limited
09 January 2026
 

9 January 2026

RUFFER INVESTMENT COMPANY LIMITED

(a closed-ended investment company incorporated in Guernsey with registration number 41966)

(the "Company")

 

Attached is a link to the Monthly Investment Report for December 2025:

http://www.rns-pdf.londonstockexchange.com/rns/2383O_1-2026-1-8.pdf

Financial markets rounded out 2025 on a more subdued note. After a year of strong returns across risk assets, global equities largely stalled in December as investors digested a flood of central bank communication ahead of the new year. The S&P 500 finished the month marginally negative, likely held back by profit‑taking in the mega‑cap complex, whilst UK and European indices drifted slightly higher. Bond yields climbed modestly, despite the expectation of further rate cuts in 2026, as positioning, inflation uncertainty and supply concerns dominated. In policy‑divergent Japan, bond yields rose as markets tested the central bank's enthusiasm for keeping interest rates low. Precious metals remained in demand as gold and silver extended their rallies before pulling back into the year end, whilst oil regained ground in the final weeks of the year, after a brief visit below $60, on renewed geopolitical tension.

 

The board also continued their buybacks. Over the final quarter, they have purchased 6.8 million shares. This brings the total for the year to 38 million shares, or £105m, which equates to 11% of the shares outstanding at the start of the year.

 

The portfolio was roughly flat in December, consolidating a solid fourth quarter and a calendar year that saw double-digit returns net of fees. The gold equities allocation was again the largest contributor as precious metal miners outperformed bullion in the earlier part of the month. Broader equity exposure also supported portfolio returns, led by a handful of idiosyncratic positions. Trading activity reflected deliberate re‑balancing. We exited the pharmaceutical basket, whose double-digit outperformance of the S&P 500 since the basket's inception validated our thesis of reduced policy uncertainty and valuation recovery. We also trimmed our mining equities mid-month. Proceeds were redeployed towards fresh sources of dry powder - additions to US and UK interest rate-sensitive equities and single stock exposure. We also doubled our direct oil exposure to around 1%, funded by trimming copper after

its sharp rally.

 

The principal drags on performance came from the derivative protections, which detracted as volatility remained low (the VIX reaching 13.5 on Christmas Eve) and credit spreads tightened further. Fixed income holdings were broadly neutral in contribution terms, but we continued to reduce portfolio duration by roughly half a year, taking advantage of the recovery in the long end of the UK curve as Budget risk cleared. Total portfolio duration now sits below two years - consistent with our view that long-dated bonds are a less reliable source of protection in an environment of elevated inflation volatility.

 

Looking to the year ahead, the macro environment remains delicately balanced. The Federal Reserve's dovish tone may sustain risk appetite, yet valuations and positioning imply the market is less able to absorb shocks. Investors are already pricing at least two more US rate cuts - a path achievable perhaps only if growth decelerates - and fiscal stimulus and political dynamics ahead of the mid-term elections could complicate the picture. Against this backdrop, we retain a disciplined stance: reinforcing exposure to attractively priced growth opportunities whilst maintaining the portfolio's defensive spine. Optimism in markets presents the opportunity to own insurance at appealing levels, allowing us to hold a mix of assets that can prosper whether 2026 delivers a sharp ascent, a soft landing or a bumpier decline.

 

Enquiries:

Apex Fund and Corporate Services (Guernsey) Limited

Company Secretary

James Taylor

DDI: +44 (0) 20 3530 3600

Email: RufferCoSec@apexgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings